Literature DB >> 35245944

Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital.

Alex C Spyropoulos1,2,3, Renato D Lopes4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35245944      PMCID： PMC8901239          DOI： 10.1182/bloodadvances.2021006871

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  16 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial.

Authors:  Eduardo Ramacciotti; Leandro Barile Agati; Daniela Calderaro; Giuliano Giova Volpiani; Caroline Candida Carvalho de Oliveira; Valéria Cristina Resende Aguiar; Elizabeth Rodrigues; Marcone Lima Sobreira; Edwaldo Edner Joviliano; Cesar Dusilek; Kenji Itinose; Rogério Aparecido Dedivitis; André Sementilli Cortina; Suzanna Maria Viana Sanches; Nara Franzin de Moraes; Paulo Fernando Guimarães Morando Marzocchi Tierno; André Luiz Malavasi Longo de Oliveira; Adriano Tachibana; Rodrigo Caruso Chate; Marcus Vinícius Barbosa Santos; Bruno Bezerra de Menezes Cavalcante; Ricardo Cesar Rocha Moreira; Chang Chiann; Alfonso Tafur; Alex C Spyropoulos; Renato D Lopes
Journal:  Am Heart J       Date:  2021-09-01       Impact factor: 5.099

3.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

4.  The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification.

Authors:  C Michael Gibson; Alex C Spyropoulos; Alexander T Cohen; Russell D Hull; Samuel Z Goldhaber; Roger D Yusen; Adrian F Hernandez; Serge Korjian; Yazan Daaboul; Alex Gold; Robert A Harrington; Gerald Chi
Journal:  TH Open       Date:  2017-06-28

5.  Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.

Authors:  Alex C Spyropoulos; Concetta Lipardi; Jianfeng Xu; Wentao Lu; Eunyoung Suh; Zhong Yuan; Bennett Levitan; Chiara Sugarmann; Yoriko De Sanctis; Theodore E Spiro; Elliot S Barnathan; Gary E Raskob
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

6.  Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.

Authors:  Alex C Spyropoulos; Stuart L Cohen; Eugenia Gianos; Nina Kohn; Dimitrios Giannis; Saurav Chatterjee; Mark Goldin; Marty Lesser; Kevin Coppa; Jamie S Hirsch; Thomas McGinn; Matthew A Barish
Journal:  Res Pract Thromb Haemost       Date:  2021-02-24

7.  Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.

Authors:  Eduardo Ramacciotti; Leandro Barile Agati; Daniela Calderaro; Valéria Cristina Resende Aguiar; Alex C Spyropoulos; Caroline Candida Carvalho de Oliveira; Jessica Lins Dos Santos; Giuliano Giova Volpiani; Marcone Lima Sobreira; Edwaldo Edner Joviliano; Milton Sérgio Bohatch Júnior; Benedito Antônio Lopes da Fonseca; Maurício Serra Ribeiro; Cesar Dusilek; Kengi Itinose; Suzanna Maria Viana Sanches; Karine de Almeida Araujo Ramos; Nara Franzin de Moraes; Paulo Fernando Guimarães Morando Marzocchi Tierno; André Luiz Malavasi Longo de Oliveira; Adriano Tachibana; Rodrigo Caruso Chate; Marcus Vinícius Barbosa Santos; Bruno Bezerra de Menezes Cavalcante; Ricardo Cesar Rocha Moreira; Chiann Chang; Alfonso Tafur; Jawed Fareed; Renato D Lopes
Journal:  Lancet       Date:  2021-12-15       Impact factor: 79.321

8.  External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.

Authors:  Mark Goldin; Stephanie K Lin; Nina Kohn; Michael Qiu; Stuart L Cohen; Matthew A Barish; Eugenia Gianos; Anise Diaz; Safiya Richardson; Dimitrios Giannis; Saurav Chatterjee; Kevin Coppa; Jamie S Hirsch; Sam Ngu; Sheila Firoozan; Thomas McGinn; Alex C Spyropoulos
Journal:  J Thromb Thrombolysis       Date:  2021-06-19       Impact factor: 5.221

9.  Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19.

Authors:  Luis H Paz Rios; Iva Minga; Esther Kwak; Ayman Najib; Ashley Aller; Elizabeth Lees; Victor Macrinici; Kaveh Rezaei Bookani; Amit Pursnani; Joseph Caprini; Alex C Spyropoulos; Alfonso Tafur
Journal:  TH Open       Date:  2021-06-22

10.  American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis.

Authors:  Adam Cuker; Eric K Tseng; Robby Nieuwlaat; Pantep Angchaisuksiri; Clifton Blair; Kathryn Dane; Jennifer Davila; Maria T DeSancho; David Diuguid; Daniel O Griffin; Susan R Kahn; Frederikus A Klok; Alfred Ian Lee; Ignacio Neumann; Ashok Pai; Marc Righini; Kristen M Sanfilippo; Deborah Siegal; Mike Skara; Deirdra R Terrell; Kamshad Touri; Elie A Akl; Reyad Nayif Al Jabiri; Yazan Nayif Al Jabiri; Angela M Barbara; Antonio Bognanni; Imad Bou Akl; Mary Boulos; Romina Brignardello-Petersen; Rana Charide; Matthew Chan; Luis E Colunga-Lozano; Karin Dearness; Andrea J Darzi; Heba Hussein; Samer G Karam; Philipp Kolb; Razan Mansour; Gian Paolo Morgano; Rami Z Morsi; Giovanna Muti-Schünemann; Menatalla K Nadim; Atefeh Noori; Binu A Philip; Thomas Piggott; Yuan Qiu; Yetiani Roldan Benitez; Finn Schünemann; Adrienne Stevens; Karla Solo; Wojtek Wiercioch; Reem A Mustafa; Holger J Schünemann
Journal:  Blood Adv       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.